Right Atrial Fibrosis in Pulmonary Hypertension
-
- STATUS
- Recruiting
-
- End date
- Nov 30, 2023
-
- participants needed
- 40
-
- sponsor
- University of Giessen
Summary
The study aim to assess right atrial (RA) remodeling, in terms of RA fibrosis, in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients. This will be investigated in detail with in-depth cardiac magnet resonance imaging (CMRI). A cohort with exclusion of pulmonary hypertension which underwent CMRI due to dyspnoe of unkown reason will be the control group.
Description
Right atrial (RA) function consists of a reservoir, conduit, and active contractile function and can serve as a tool for the evaluation of the severity of RV dysfunction and prognosis in pulmonary hypertension according to recent data. In-depth evaluation of phasic RA function was previously undertaken either by echocardiographic speckle tracking or by cardiac magnetic resonance (CMR) imaging-derived feature tracking. However, it is currently unknown if right atrial remodeling is present.
As described for left atrial fibrosis, the presence and extent of atrial fibrosis can be quantified using CMR late gadolinium enhancement. The protocol for the assessment of left atrial fibrosis will be used and adapted to the RA. Patients will undergo 3-dimensional late gadolinium enhancement CMRI along with a contrast-enhanced magnetic resonance angiography and cine imaging in order to define the anatomy of the RA and the superior and inferior vein. High-resolution late gadolinium enhancement images of the RA will be acquired 15 to 30 min after gadolinium-based contrast agents administration using a 3-dimensional inversion-recovery prepared, respiration navigated, and electrocardiogram triggered gradient-echo pulse sequence with fat saturation. Following acquisition of the scans, the endocardial borders of the RA will be defined in each slice by manual tracing. After manual adjustment of the epicardial RA surface, the quantification of fibrosis based on the relative intensity (signal intensity) of late gadolinium enhancement will be performed. Finally, a 3-dimensional model of the RA will be rendered with the maximum enhancement intensities being projected on the model surface.
Details
| Condition | Primary Insulin Hypersecretion, Late Infantile Neuronal Ceroid Lipfuscinsosis, Complicated Grief, Dental Filling, Chronic Pelvic Pain, Nerve Injury, thromboembolic pulmonary hypertension, Infantile Fibrosarcoma, Pulmonary Arterial Hypertension, Pseudobulbar Affect, Memory Problems, Pelvic Adhesions, Low Testosterone, Catheter Complications, Open Heart Surgery, Functional Dyspepsia, Renal Anemia, Joint Injuries, Testotoxikose, Cancer Treatment, Myopic Macular Degeneration, Recurrent Pregnancy Loss, Surviving Abuse, Stasis Dermatitis, Serial Evaluation of Ductal Epithelium, Spine Athroplasty, Mental Disability, Severe Premenstrual Symptom, Chronic Renal Anemia, Gambling Problems, Effects of Chemotherapy, Indikation: Diabetes - Typ II, Pulmonary Hypertension, Partial Medial Meniscectomy, Abdominal Surgery, Habit Reversal, Anemic Cancer, Spinocerebellar Disorders, Chronic Thromboembolic Pulmonary Hypertension, CTEPH, Cancer Prevention |
|---|---|
| Treatment | Cardiac magnetic resonance imaging |
| Clinical Study Identifier | NCT04663230 |
| Sponsor | University of Giessen |
| Last Modified on | 17 November 2021 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer